Comparison of Endoscopic and Laparoscopic Resection for Small Gastric Gastrointestinal Stromal Tumor

NCT ID: NCT03471273

Last Updated: 2018-03-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

900 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-18

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of Endoscopic and Laparoscopic Resection for Small Gastric Gastrointestinal Stromal Tumor

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Therapeutic Value of Endoscopic and Laparoscopic Resection for Small Gastric Gastrointestinal Stromal Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

endoscopic management

Group Type OTHER

endoscopic management, surgery and follow up

Intervention Type PROCEDURE

endoscopic management, surgery and follow up

follow up

Group Type OTHER

endoscopic management, surgery and follow up

Intervention Type PROCEDURE

endoscopic management, surgery and follow up

surgery

Group Type OTHER

endoscopic management, surgery and follow up

Intervention Type PROCEDURE

endoscopic management, surgery and follow up

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

endoscopic management, surgery and follow up

endoscopic management, surgery and follow up

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-70 years old Chinese;
* Definite diagnosis or endoscopic ultrasonography, CT and other highly suspected Chinese patients with gastric stromal tumors;
* Patients voluntarily signed informed consent and have been orally informed of the specific trial plan.

Exclusion Criteria

* Patients with gastric stromal tumors with distant metastasis who cannot be treated by laparoscopic surgery;
* Combined heart , cerebrovascular , liver , kidney , and hematopoietic system serious primary disease;
* gastric stromal tumors with severe digestive tract hemorrhage endanger the immediate surgical treatment of life;
* The investigator considers that it is not suitable for this test.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shenzhen Hospital of Southern Medical University

OTHER

Sponsor Role collaborator

Nanfang Hospital, Southern Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nanfang Hospistal

Guangzhou, Guangdong, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lan Bai, Doctor

Role: CONTACT

15692428926

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Fang Xie, Doctor

Role: primary

15692428926

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LC2016ZD013

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.